Literature DB >> 7711740

Assignment of an Usher syndrome type III (USH3) gene to chromosome 3q.

E M Sankila1, L Pakarinen, H Kääriäinen, K Aittomäki, S Karjalainen, P Sistonen, A de la Chapelle.   

Abstract

Usher syndrome (USH) refers to genetically and clinically heterogeneous autosomal recessive disorders with combined visual and hearing loss. Type I (USH1) is characterized by a congenital, severe to profound hearing loss and absent vestibular function; in type II (USH2) the hearing loss is congenital and moderate to severe, and the vestibular function is normal. Progressive pigmentary retinopathy (PPR) is present in both types. A third type (USH3) differing from USH2 by the progressive nature of its hearing loss has been suggested. USH3 has previously been estimated to comprise 2% of all USH. However, based on clinical criteria, in Finland 42% of USH patients have progressive hearing loss suggesting enrichment of an USH3 gene. We excluded the four previously mapped USH regions as the site of the USH3 disease locus. Systematic search for USH3 by genetic linkage analyses in 10 multiple affected families using polymorphic microsatellite markers revealed significant linkage with markers mapping to chromosome 3q. Pairwise lod scores at zero recombination distance were 7.87 for D3S1308, and 11.29 for D3S1299, incorporating the observed linkage disequilibrium. Conventional multipoint linkage analysis gave a maximum lod score of 9.88 at D3S1299 assigning USH3 to the 5 cM interval between markers D3S1555 and D3S1279 in 3q21-25.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7711740     DOI: 10.1093/hmg/4.1.93

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  27 in total

1.  Highly skewed X-chromosome inactivation is associated with idiopathic recurrent spontaneous abortion.

Authors:  M C Lanasa; W A Hogge; C Kubik; J Blancato; E P Hoffman
Journal:  Am J Hum Genet       Date:  1999-07       Impact factor: 11.025

Review 2.  The Finnish Disease Heritage III: the individual diseases.

Authors:  Reijo Norio
Journal:  Hum Genet       Date:  2003-03-08       Impact factor: 4.132

3.  Usher syndrome in the city of Birmingham--prevalence and clinical classification.

Authors:  C I Hope; S Bundey; D Proops; A R Fielder
Journal:  Br J Ophthalmol       Date:  1997-01       Impact factor: 4.638

4.  Linkage disequilibrium mapping in isolated populations: the example of Finland revisited.

Authors:  A de la Chapelle; F A Wright
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

5.  Identification of direct downstream targets of Dlx5 during early inner ear development.

Authors:  Samin A Sajan; John L R Rubenstein; Mark E Warchol; Michael Lovett
Journal:  Hum Mol Genet       Date:  2011-01-12       Impact factor: 6.150

6.  Genetic heterogeneity of Usher syndrome type II in a Dutch population.

Authors:  S Pieke-Dahl; A van Aarem; A Dobin; C W Cremers; W J Kimberling
Journal:  J Med Genet       Date:  1996-09       Impact factor: 6.318

7.  Pendred syndrome: evidence for genetic homogeneity and further refinement of linkage.

Authors:  E Gausden; B Coyle; J A Armour; R Coffey; A Grossman; G R Fraser; R M Winter; M E Pembrey; P Kendall-Taylor; D Stephens; L M Luxon; P D Phelps; W Reardon; R Trembath
Journal:  J Med Genet       Date:  1997-02       Impact factor: 6.318

8.  Usher syndrome type III (USH3) linked to chromosome 3q in an Italian family.

Authors:  P Gasparini; A De Fazio; A I Croce; P Stanziale; L Zelante
Journal:  J Med Genet       Date:  1998-08       Impact factor: 6.318

9.  Biochemical characterization of native Usher protein complexes from a vesicular subfraction of tracheal epithelial cells.

Authors:  Marisa Zallocchi; Joseph H Sisson; Dominic Cosgrove
Journal:  Biochemistry       Date:  2010-02-16       Impact factor: 3.162

10.  CLRN1 is nonessential in the mouse retina but is required for cochlear hair cell development.

Authors:  Scott F Geller; Karen I Guerin; Meike Visel; Aaron Pham; Edwin S Lee; Amiel A Dror; Karen B Avraham; Toshinori Hayashi; Catherine A Ray; Thomas A Reh; Olivia Bermingham-McDonogh; William J Triffo; Shaowen Bao; Juha Isosomppi; Hanna Västinsalo; Eeva-Marja Sankila; John G Flannery
Journal:  PLoS Genet       Date:  2009-08-14       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.